Books by Subject


  • 2007 Springer
    edited by Judith E. Karp.
    Approaching the treatment of AML from a biological perspective : an overview / Farhad Ravandi and Francis Giles -- Aberrant transcription factors in AML / Alan D. Friedman -- Myelodysplasia-related AML / Jane E. Parker -- Therapy-related AML / Lucy A. Godley and Michelle Le Beau -- The DNA damage response, DNA repair, and AML / David P. Steensma -- Altered apoptosis in AML : potential implications for pathogenesis and therapeutic response / Ruben A. Mesa and Scott H. Kaufmann -- Drug resistance transporters in AML / Douglas D. Ross -- Impact of cytogenetics on clinical outcome in AML / David Grimwade -- APL : a classic tale of bench to bedside / Olga Frankfurt ... [et al.] -- Emerging therapeutics for AML / Edward A. Sausville -- FLT3 : a prototype receptor tyrosine kinase target in AML / Mark Levis -- Farnesyl transferase inhibitors in the therapy of AML / Jeffrey E. Lancet -- Modulating gene expression as a therapeutic approach in the treatment of AML / Tamer Fandy, Hetty Carraway, and Steven D. Gore -- Differentiation therapy in AML / Tara L. Lin and William Matsui -- Stem cell transplantation for AML / Javier Bolaños-Meade and Richard J. Jones -- Tumor vaccines in leukemia / Ivan Borrello -- Treatment, outcomes, and challenges of newly diagnosed AML in children and adolescents / Robert J. Arceci -- AML in older adults / Richard M. Stone -- Dameshek smiles : molecular clues to the chronic myeloproliferative disorders unmasked / Jason Gotlib -- New designs for clinical trials / Elihu Estey.
    Also available: Print – 2007
  • 2010 Springer
    Lalitha Nagarajan, editor.
    Also available: Print – 2010
  • 2011 Springer
    edited by Anjali Advani and Hillard Lazarus.
    A perspective on the treatment of acute lymphoblastic leukemia in adults -- Acute lymphocytic leukemia: clinical features and making the diagnosis -- The biology of adult acute lymphoblastic leukemia -- Minimal residual disease in acute lymphoblastic leukemia -- Cytogenetics -- Acute lymphoblastic leukemia: epidemiology -- Prognostic factors in adult acute lymphoblastic leukemia (ALL) -- The generalized care of the patient with acute lymphoblastic leukemia -- Treatment of acute lymphoblastic leukemia in middle-age and older adults -- Pharmacology of acute lymphoblastic leukemia therapy -- Assessment of response to treatment -- T-cell acute lymphoblastic leukemia -- Burkitt lymphoma and leukemia -- Treatment of acute lymphoblastic leukemia in young adults -- Philadelphia chromosome positive acute lymphoblastic leukemia -- Molecular therapies -- Treatment of relapsed acute lymphoblastic leukemia -- Allogeneic stem cell transplantation for acute lymphoblastic leukemia in adults -- Hematopoietic stem cell transplantation in Philadelphia-positive acute lymphoblastic leukemia -- Special challenges: genetic polymorphisms and therapy -- Late consequences of therapy of acute lymphoblastic leukemia -- Immunotherapy for acute lymphoblastic leukemia -- Unique subtypes in acute lymphoblastic leukemia.
  • 2013 Springer
    Sami Malek, editor.
    Chronic lymphocytic leukemia (CLL) is the most common leukemia in the Western world. CLL has a highly varied clinical course. While advances in CLL therapy are noted, many patients still succumb to this illness. Like most progress in medicine, solid advances in the diagnosis, prognosis and treatment of CLL are rooted in an in-depth understanding of the basic and translational biology of CLL. In this book, CLL experts have contributed state-of-the-art summaries of various important aspects of CLL biology and have discussed the translational implication of such findings. This book, which is directed at physicians and researchers alike, aims to educate broadly and deeply. Intentionally, the many aspects and nuances of CLL clinical care that can only really be appreciated through direct patient care are not covered here, but instead, the book presents basic aspects of CLL that underlie many of the contemporary decisions that are made in CLL research and clinical settings. We hope that this book will critically inform the community and stimulate interest in CLL, which will ultimately translate into better CLL research, prognostication and therapy, with the end goal of providing a better outlook for patients afflicted with this common leukemia.
    Also available: Print – 2013
  • 2014 Future Med
    editor, Wilbert S. Aronow.
    Advances in dyslipidemia / Wilbert S. Aronow -- Atherosclerosis : dyslipidemia, inflammation and lipoapoptosis / Fleur M. van der Valk, Dominik M. Schulte, Willem J.M. Mulder & Erik S.G. Stroes -- Familial hypercholesterolemia : bridging and minding the gap in healthcare / Jing Pang, Alistair W. Vickery & Gerald F. Watts -- PCSK9 inhibition : drug development for low-density lipoprotein lowering / Geetha Mukerji, Rawand M. Abdin & Dominic S. Ng -- Novel therapies for dyslipidemia / Anthony S. Wierzbicki -- The highs and lows of high-density lipoprotein / Daniel Soffer & Marisa Schoen -- Do we need to treat patients with heart failure with statins? / Sadip Pant, Guru S. Gurumurthy, Abhishek Deshmukh & Jawahar L. Mehta -- Management of dyslipidemia in patients with nonalcoholic fatty liver disease / Konstantinos Tziomalos, Vasilios G. Athyros & Asterios Karagiannis -- Dyslipidemia : current management and the challenge of residual cardiovascular risk reduction / Aaron Rockoff, Vaijinath S. Kamanna & Moti L. Kashyap -- Index.
  • 2012 Future Med
    editors, Michael J. Keating, Constantine Tam.
    Advances in the treatment of B-cell chronic lymphocytic leukemia / Michael J. Keating & Constantine Tam -- Chronic lymphocytic leukemia : diagnosis and clinical staging / Stephen P. Mulligan & Constantine S. Tam -- Genetics in chronic lymphocytic leukemia / Stephan Stilgenbauer & Thorsten Zenz -- To treat or not to treat / Marco Montillo, Alessandra Tedeschi & Enrica Morra -- Chronic lymphocytic leukemia chemotherapy : two decades of progress / Carol Moreno & Emili Montserrat -- Stem cell transplantation / David G. Maloney -- Treatment options for refractory chronic lymphocytic leukemia / Marina Motta & Alessandra Ferrajoli -- Prognostic markers in chronic lymphocytic leukemia / Renata Walewska & David Oscier -- Therapeutic agents in development and future direction / Sarah Mougalian & Susan O'Brien -- Index.
  • 2013 Future Med
    editors, Giuseppe Saglio, Carmen Fava.
    Advances in the treatment of chronic myeloid leukemia / Giuseppe Saglio & Carmen Fava -- Diagnosis and classification of the risk / Gabriele Gugliotta, Fausto Castagnetti, Francesca Palandri, Michele Baccarani & Gianantonio Rosti -- Genetics of chronic myeloid leukemia / Giovanna Rege-Cambrin, Emilia Giugliano & Patrizia Scaravaglio -- Molecular monitoring / Martin C. Müller, Christian Dietz & Benjamin Hanfstein -- Current targeted therapy with tyrosine kinase inhibitors / Massimo Breccia & Giuliana Alimena -- Stem cell transplantation and high-dose chemotherapy / Deena Iskander, Jane F. Apperley & Jirí Pavlu -- Treatment options for tyrosine kinase inhibitor-resistant chronic myeloid leukemia / Stephan Joseph Dorkhom, Hady Ghanem & Elias Jabbour -- Prognostic factors and future direction for chronic myeloid leukemia / David Marin & Antonia Rotolo -- Chronic myeloid leukemia : the possibility of a cure / Manuel Sobrinho-Simões, David M. Ross & Junia V. Melo -- Index.
  • 2015 Springer
    Alessandro Plebani, Vassilios Lougaris, editors.
    This book provides an updated overview of agammaglobulinemia, a rare form of primary immunodeficiency which is considered the prototype of the congenital humoral defects, and which is characterized by the absence of peripheral B cells and very low serum immunoglobulin levels. The book opens by discussing the highly orchestrated early B cell development in the bone marrow and the genes involved based on both human and animal models. The pathogenesis and clinical presentation of X-linked agammaglobulinemia, caused by mutations in the BTK (Bruton's tyrosine kinase) gene, are then presented in detail, followed by descriptions of the clinical manifestations and molecular basis of the less frequent autosomal recessive and autosomal dominant forms of agammaglobulinemia. Patients' management in terms of respiratory complications, gammaglobulin replacement therapy and the potential value of novel experimental therapeutic strategies are discussed. The book's closing chapters offer a comprehensive and updated description of mutations in the BTK gene, and the expression and function of BTK in cells other than B cells.
  • 2010 Springer
    edited by Hillard M. Lazarus, Mary J. Laughlin.
  • 2010 Springer
    edited by Morie A. Gertz, S. Vincent Rajkumar.
    Fibril structure and fibrillogenesis -- Imaging of systemic amyloidosis -- Diagnosis and classification -- Pathogenesis of systemic amyloidoses -- Supportive care for amyloidosis -- Assessing response and prognosis in AL amyloidosis -- Localized amyloidosis -- Amyloid heart disease -- Renal amyloidosis -- Primary systemic amyloid neuropathy -- Conventional treatment of amyloidosis -- High-dose therapy in amyloidosis -- Secondary, AA, amyloidosis -- ATTR: diagnosis, prognosis, and treatment -- Other systemic forms of amyloidosis.
  • 2007 Springer
    edited by William D. Figg and Judah Folkman.
  • 2008 CRCnetBASE
    G.O. Evans.
    Hemopoiesis, blood cell types, and bone marrow examination -- Erythrocytes, anemias, and polycythemia -- Additional erythrocytic measurements -- Iron, associated proteins, and vitamins -- Leukocytes -- Immunotoxicology -- Hemostasis -- Pre-analytical variables -- Analytical variables and biosafety -- Data processing and interpretation.
  • 2016 Springer
    Christopher M. Loftus, editor.
    Part 1. General Principles -- Physiology of Hemostasis -- Laboratory Assessment of Physiologic and Pathologic Hemostasis -- Current Anticoagulation Drugs and Mechanisms of Action -- Reversal of Target-Specific Oral Anticoagulants -- Overview, Treatment, Measurement, and Modification of Platelet Function -- Role of Antiplatelet Therapy in Neurosurgery: Efficacy and Safety Profiles -- Part 2. Coagulation Issues Across all Patient Spectrums -- Congenital Coagulation Disorders -- Acquired Coagulation Disorders -- Regulation and Dysregulation of Fibrinolysis -- Risks Associated with Administration of Allogeneic Blood Components -- Common Coagulation Disorders That May Arise Intraoperatively -- Evaluation and Management of Untoward Intraoperative Bleeding -- Treatment of Disseminated Intravascular Coagulation (DIC) -- Heparin-Induced Thrombocytopenia (HIT) -- Anticoagulation in Cardiovascular Diseases -- Workup and Treatment of Pulmonary Embolus -- Part 3. Coagulation Issues Specific to Neurosurgery -- Classes of Drugs and Blood Products for Acute Reversal of Anticoagulant Effect -- Rescue Strategies to Facilitate Emergency Neurosurgery in Patients on Antiplatelet or Anticoagulant Agents -- Considerations for Coagulation in the Multi-Trauma Patient -- Cerebral Venous Sinus Thrombosis -- Coagulation Studies in Preoperative Neurosurgery Patients -- Safe Strategies for Gradual Suspension and Re-institution of Anticoagulation to Permit Elective Surgery -- Spontaneous Intracerebral Hemorrhage due to Coagulation Disorders -- Prophylactic Screening for Venous Thromboembolism in Neurosurgical Patients -- Venous Thromboembolism Prophylaxis in Neurosurgery -- Can Patients with Known Intracranial and Intraspinal Vascular Lesions be Anticoagulated? -- Intrathecal Access and Devices in Patients on Antiplatelet or Anticoagulant Therapy -- Is it Safe to Shunt Anti-coagulated NPH Patients? -- Surgical Hemostasis in the Era of Anticoagulation: Guidelines and Recommendations Summary.
  • 2012 Springer
    Paolo Gresele, Gustav V. R Born, Carlo Patrono, Clive P. Page, editors.
    Part 1. Pathophysiology. Platelets: Production, Morphology and Ultrastructure / Jonathan N. Thon and Joseph E. Italiano -- Platelet Receptors / Alexandre Kauskot and Marc F. Hoylaerts -- Platelet Signaling / Timothy J. Stalker, Debra K. Newman, Peisong Ma, Kenneth M. Wannemacher and Lawrence F. Brass -- Platelet Interaction with the Vessel Wall / Philip G. de Groot, Rolf T. Urbanus and Mark Roest -- Platelets in Atherosclerosis and Thrombosis / Christian Schulz and Steffen Massberg -- Part 2. Pharmacology. Aspirin and Other COX-1 Inhibitors / Carlo Patrono and Bianca Rocca -- Thienopyridines and Other ADP-Receptor Antagonists / Isabell Bernlochner and Dirk Sibbing -- Glycoprotein IIb/IIIa Antagonists / Karen M. Hook and Joel S. Bennett -- Targeting Phosphodiesterases in Anti-platelet Therapy / Matthew T. Rondina and Andrew S. Weyrich -- PAR-1 Inhibitors: A Novel Class of Antiplatelet Agents for the Treatment of Patients with Atherothrombosis / Sergio Leonardi and Richard C. Becker -- Thromboxane Receptors Antagonists and/or Synthase Inhibitors / Giovanni Davì, Francesca Santilli and Natale Vazzana -- Inhibitors of the Interaction Between von Willebrand Factor and Platelet GPIb/IX/V / Paolo Gresele and Stefania Momi -- Inhibitors of the Interactions Between Collagen and Its Receptors on Platelets / Hans Deckmyn, Simon F. De Meyer, Katleen Broos and Karen Vanhoorelbeke -- Intracellular Signaling as a Potential Target for Antiplatelet Therapy / Patrick Andre -- Novel Targets for Platelet Inhibition / Kathleen Freson and Chris Van Geet -- Variability of Platelet Indices and Function: Acquired and Genetic Factors / Giovanni de Gaetano, Iolanda Santimone, Francesco Gianfagna, Licia Iacoviello and Chiara Cerletti -- Small RNAs as Potential Platelet Therapeutics / Leonard C. Edelstein and Paul F. Bray -- Pharmacological Modulation of the Inflammatory Actions of Platelets / Richard Amison, Clive Page and Simon Pitchford -- Part 3. Therapy. The Role of Laboratory Monitoring in Antiplatelet Therapy / Marco Cattaneo -- Antiplatelet Agents in Ischemic Heart Disease / Christopher H. May and A. Michael Lincoff -- Antiplatelet Therapy in Cerebrovascular Disorders / Ralph Weber, Johannes Brenck and Hans-Christoph Diener -- Antiplatelet Therapy in Peripheral Artery Disease / Francesco Violi, Stefania Basili, Jeffrey S. Berger and William R. Hiatt -- Primary Prevention of Ischaemic Cardiovascular Disorders with Antiplatelet Agents / Tom Mead.
  • 2013 Springer
    Albert Ferro, David A. Garcia, editors.
    Antiplatelet Agents: Current and Novel -- Antiplatelet Drug Resistance and Variability in Response: The Role of Antiplatelet Therapy Monitoring -- Anticoagulant Drugs: Current and Novel -- Antithrombotic Treatment of Cardiovascular Disease -- Approaches to the Prophylaxis and Treatment of Venous and Cardiac Thromboembolic Disease.
  • 2014 Wiley
    edited by Ron Waksman, Paul A. Gurbel, Michael A. Gaglia, Jr.
  • 2010
    editors, Bruce C. McLeod, Zbigniew (Ziggy) M. Szczepiorkowski, Robert Weinstein, Jeffrey L. Winters.
    Status: Not Checked OutLane Catalog Record
    1. Development of apheresis instrumentation -- 2. Applications history -- 3. Physiology of apheresis -- 4. Current instrumentation for apheresis -- 5. Selection and care of apheresis donors -- 6. Automated donations: plasma, red cells, and multicomponent donor procedures -- 7. Apheresis platelet collection, storage, quality assessment, and clinical use -- 8. Provision of apheresis platelet transfusions: patient and producer perspectives -- 9. Matched apheresis platelets -- 10. Bacterial contamination of platelet products -- 11. Granulocyte (neutrophil) transfusion -- 12. Management of the therapeutic apheresis patient -- 13. Therapeutic leukocyte and platelet depletion -- 14. Basic principles of therapeutic blood exchange -- 15. Therapeutic apheresis in neurologic disorders -- 16. Therapeutic plasma exchange in hematologic diseases and dysproteinemias -- 17. Therapeutic plasma exchange for renal and rheumatic diseases -- 18. Apheresis in solid organ transplantation -- 19. Red cell exchange and other therapeutic alterations of red cell mass -- 20. Selective extraction of plasma constituents -- 21. Therapeutic apheresis in pediatric patients -- 22. Hematopoietic stem cell transplantation: an overview -- 23. Mobilization and collection of peripheral blood hermatopoietic progenitor cells -- 24. Receipt, processing, and infusion of hematopoietic progenitor and therapeutic cells -- 25. Regenerative medicine -- 26. Autologous cellular immunotherapies -- 27. Allogeneic adoptive immunotherapy with apheresis products -- 28. Photopheresis -- 29. Cellular gene therapy -- 30. Regulatory environment for apheresis facilities and personnel -- 31. Principles of quality management for apheresis facilities -- 32. Quality management of apheresis personnel -- Index.
  • 2009 Springer
    Tsieh Sun, editor.
  • 2013 Springer
    Dennis P. O'Malley.
    1. Normal Morphologic and Immunohistochemical Findings and Hyperplasias -- 2. Congenital Malformations and Abnormalities of Spleen Location and Histology -- 3. Lmphoid Neoplasms -- 4. Myeloid and Related Disorders -- 5. Nonhematopoietic Lesions Including Vascular -- 6. Reactive and Systemic Conditions -- 7. Infections.
  • 2013 Wiley
    Petra Seeber, Aryeh Shander.
  • 2011 Springer
    JoAnn M. Mould, Paul M. Ness, Steve R. Sloan, editors.
    This text is a review of molecular immunohematology (MI). It draws from analyses and case studies around the world and details many techniques used in many labs. It is aimed at anyone interested in how MI is changing blood bank and transfusion medicine.
  • 2017 Springer
    Todd M. Zimmerman, Shaji K. Kumar, editors.
  • 2011 Springer
    Eyal Sheiner, editor.
    Clinical Approach to Pregnancy-Related Bleeding -- Early Pregnancy Loss -- Ectopic Pregnancy -- Vaginal Bleeding and Gestational Trophoblastic Disease -- Gynecological Cancer During Pregnancy -- Vaginal Bleeding and Preterm Delivery -- Placental Abruption -- Placenta Previa and Placenta Accreta -- Vasa Previa -- Uterine Rupture -- Postpartum Hemorrhage -- Coagulopathy and Pregnancy -- Anesthesia and Intensive Care Management of Bleeding During Pregnancy.
  • 2011 ScienceDirect
    2011 ClinicalKey
    [edited by] Anna Porwit, Jeffrey McCullough, Wendy N. Erber.
    1. Normal blood cells -- 2. Normal bone marrow cells: development and cythology -- 3. Normal bone marrow histology -- 4. Regulation of hematopoiesis -- 5. Pathology of the marrow: general considerations and infections/reactive conditions -- 6. Investigation and classification of anemia -- 7. Abnormalities of the red cell membrane -- 8. Erythroenzyme disorders -- 9. Abnormalities of the structure and synthesis of hemoglobin -- 10. Acquired hemolytic anemia -- 11. Iron deficiency anemia, anemia with chronic disorders and iron overload -- 12. Macrocytic anemia -- 13. Aplastic anemia and pure red cell aplasia -- 14. Sideroblastic anemia -- 15. Congenital dyserythropoietic anemias -- 16. Abnormalities in leukocyte morphology and number -- 17. Disorders of phagocyte function -- 18. Acute myeloid leukemias -- 19. Acute lymphoblastic leukemia/lymphoma and mixed phenotype acute leukemias -- 20. Myelodysplastic syndromes -- 21. Molecular studies in myeloproliferative and myelodysplastic/myeloproliferative neoplasms -- 22. Erythrocytosis and polycythemia -- 23. Essential thrombocythemia and primary myelofibrosis -- 24. Chronic myelogenous leukemia -- 25. Myeloproliferative neoplasms and eosinophilia -- 26. Systemic mastocytosis -- 27. Myelodysplastic/myeloproliferative neoplasms -- 28. The chronic lymphoid leukemias -- 29. Lymphoma -- 30. Abnormalities in immunoglobulin synthesizing cells -- 31. Hemostasis : principles of investigation -- 32. Disorders affecting megakaryocytes and platelets : inherited conditions -- 33. Acquired disorders affecting megakaryocytes and platelets -- 34. Inherited disorders of coagulation -- 35. Acquired bleeding disorders -- 36. Natural anticoagulants and thrombophilia -- 37. Blood groups on red cells, platelets and neutrophils -- 38. Transfusion medicine for pathologists -- 39. Histocompatibility : HLA and other systems.
  • 2015 Springer
    Richard T. Maziarz, Susan Schubach Slater, editors.
  • 2011 Springer
    Richard T. Maziarz, Susan Slater.
    Overview of hematopoietic stem cell transplantation -- The business of cellular therapy and hematopoietic stem cell transplantation -- Stem cell sources -- Pre-transplant evaluation -- Conditioning regimens -- Supportive care -- Nutrition -- Infection prophylaxis -- Graft-versus-host disease prophylaxis -- Transfusion medicine -- Antithrombotic guidelines -- Engraftment -- Follow-up care -- Infectious complications -- Acute graft-versus-host disease -- Chronic graft-versus-host disease -- Oral complications -- Gastrointestinal complications -- Pulmonary complications -- Cardiovascular complications -- Acute kidney injury -- Thrombotic microangiopathies -- Graft failure -- Post-transplant relapse -- Palliative care -- Survivorship.
  • 2014 Wiley
    edited by Bipin N. Savani.
    Introduction / Bipin N. Savani -- Overview : transplant data and increasing numbers of long-term survivors / Jakob R. Passweg and Helen Baldomero -- Long-term transplant clinic setup / Andre Tichelli ... [et al.] -- Late effects after allogeneic hematopoietic stem cell transplantation / Sairah Ahmed and Yago Nieto -- Late effects after autologous hematopoietic stem cell transplantation / Sairah Ahmed and Yago Nieto -- Graft-versus-host disease and late effects after hematopoetic stem cell transplantation / Gerard Socie -- Prominent role of allied health professionals (nurse practitioners, physician assistants, others) in long term follow-up after hematopoietic stem cell transplantation / Catherine E. Lucid -- Screening and prevention guidelines for hematopoietic cell transplant survivors / Navneet S. Majhail and j. Douglas Rizzo -- Secondary malignancies : prevalence, screening, prevention, and management guidelines / Paolo F. Caimi and Hillard M. Lazarus -- Cutaneous chronic graft-versus-host disease / Attilio Olivieri ... [et al.] -- Anti-infective prophylaxis, immunization and prevention of recurrent infectious complications in long-term survivors / John P. Galvin and Jayesh Mehta -- Seasonal virus infections : prevention and management guidelines / Gaurav Trikha and John R. Wingard -- Exposure to family members : infections and recent live vaccinations / Brian G. Engelhardt and James E. Crowe, Jr. -- Late pulmonary complications after allogeneic hematopietic stem cell transplantation : bronchiolitis obliterans syndrome (BOS) and organizing pneumonia (OP) / Lee Gazourian ... [et al.] -- Post-transplantation bone disease : prevalence, monitoring, prevention and management guidelines / Andre Tichelli and Alicia Rovo -- Ocular complications : prevalence, monitoring, prevention, and management guidelines / Andre Tichelli and Alicia Rovo -- Oral complications in hematopoietic stem cell transplantation survivors : monitoring and management / Andrea L. Utz and Shubhada Jagasia -- Fertility issues, contraception, and pregnancy outcome in long-term survivors / Alicia Rovo ... [et al.] -- Follow-up of children after hematopoietic stem cell transplantation : growth and development / Kristina K. Hardy ... [et al.] -- Posttransplant diabetes mellitus : monitoring, prevention, and management guidelines / Prathima Jasti, Shichun Bao, and Shubhada Jagasia -- Thyroid disease : monitoring and mangement guidelines / M. Kathleen Figaro ... [et al.] -- Special issues related to female long-term survivors / Melissa A. Merideth ... [et al.] -- Cardiac and vascular complications in long-term survivors after hematopoietic stem cell transplantation / Alicia Rovo and Andre Tichelli -- Hyperlipidemia : prevalence, monitoring, management, interactions with immunosuppressive agents and follow-up / Dara L. Eckerle Mize, Shubhada Jagasia, and Jeffrey B. Boord -- Hypertension management in long-term survivors / Imad Abboud -- Gastrointestinal complications of hematopoietic cell transplantation / Preet Bagi ... [et al.] -- Hepatic complications of hematopoietic stem cell transplantation / Niharika Samala ... [et al.] -- Monitoring and management of hepatitis B, hepatitis C, and HIV infection before and after transplantation / Keith Luckett and Stephen Dummer -- Prevention and management of renal complications in long-term survivors / Michael Dickenmann and Joerg P. Halter -- Immunosuppressive agents and monitoring in long-term survivors / Paul Shaughnessy and Helen Leather -- Nutritional assessments and nutritional supplementation for long-term transplant survivors : multivitamins, vitamin D, Calcium, antioxidants, and minerals / Lauren Zatarain ... [et al.] -- Daily routines and guidelines : driving, infection isolation, masks, food/diet, activities, exercise, pets, sun exposures, and others / Angela M. Woods -- Caregivers of long-term survivors / Elizabeth Wulff-Burchfield -- Health-related quality of life in adult and pediatric survivors of hematopoietic stem cell transplantation / Margaret Bevans and Lori Wiener -- Prevalent psychosocial adjustment issues nd solutions : lifestyle and social challenges / Katrina M. Stokes -- Patient's perspective : concepts of long-term survivor support groups and their roles / Michael W. Brown -- Appendix 1 NMDP/Be the match posttransplant guidelines resources / Darlene Haven -- Appendix 2 Long-term follow-up calendar / Andre Tichelli ... [et al.] -- Appendix 3 Commonly used transplant-related medications in long-term survivors / Melissa Logue.
  • 2006 ScienceDirect
    edited by Robert M. Winslow.
  • 2008 CRCnetBASE
    Tom Bevel and Ross M. Gardner.
    1. Bloodstain Pattern Analysis: Its Function and a Historical Perspective -- 2. Bloodstain Pattern Terminology -- 3. Bloodstain Classification -- 4. A Methodology for Bloodstain Pattern Analysis -- 5. The Medium of Blood -- 6. Anatomical Considerations in Bloodstain Pattern Analysis -- 7. Determining Motion and Directionality -- 8. Determining the Point of Convergence and the Area of Origin -- 9. Evaluating Impact Spatter Bloodstains -- 10. Understanding and Applying Characteristic Patterns of Blood -- 11. Bloodstained Clothing Issues -- 12. Presumptive Testing and Enhancement of Blood / Charlene Marie -- 13. Documenting Bloodstains -- 14. An Introduction to Crime Scene Reconstruction and Analysis -- 15. Presenting Evidence 16. Experimentation in Bloodstain Pattern Analysis -- 17. Dealing with the Risk of Bloodborne Pathogens -- Appendix A. Weight/Measurement Conversion Table -- Appendix B. Trigonometric Functions and Their Application in Bloodstain Pattern Analysis.
  • 2012 Springer
    Dimitra Anagnostou, Estella Matutes, editors.
    1. New Insights in the Development of Human B Lymphocytes / Bianca Blom -- 2. The Aging Lymphocyte / Hector F. Valenzuela, Rita B. Effros -- 3. The Bone Marrow Microenvironment and Its Impact in Acute and Chronic B Cell Malignancies / Jan A. Burger -- 4. The Expanding Diagnostic Role of Flow Cytometry in Bone Marrow Studies of Patients with Lymphomas and Plasma Cell Disorders / Anna Porwit -- 5. The Application of Molecular Techniques on Bone Marrow Trephines / Falko Fend, Leticia Quintanilla-Martínez -- 6. Residual Disease Assessment and Its Role in Monitoring Lymphoid and Plasma Cell Neoplasms / Konnie M. Hebeda -- 7. Reporting of Bone Marrow Lymphoid Infiltrates / Yi-Hua Chen, LoAnn Peterson -- 8. Janus-Faced Lymphoid Infiltrates / Dimitra Anagnostou -- 9. Singularities in Pediatric Bone Marrow Lymphoid Processes / Sophia L. Yohe, Robert W. McKenna -- 10. Bone Marrow Involvement in Primary Mature B and T Cell Leukemias / Ayoma D. Attygalle -- 11. A Step Forward in the Diagnosis of B-Cell Lymphomas in the Bone Marrow / Ahmet Dogan, Mine Hekimgil -- 12. New Insights in Waldenström's Macroglobulinemia / Meletios A. Dimopoulos, Evangelos Terpos -- 13. Bone Marrow in Hodgkin Lymphoma and Mimickers / Stefano A. Pileri, Elena Sabattini -- 14. Misleading Features of Bone Marrow Involvement by Peripheral T-Cell Lymphomas / Philippe Gaulard, Sylvia Hoeller -- 15. Systemic Mastocytosis Associated with Lymphoproliferative Disorders (SM-AHNMD) / Hans-Peter Horny, Karl Sotlar, Peter Valent.
  • 2015 Springer
    Lia Angela Moulopoulos, Vassilis Koutoulidis.
    MRI provides the best means of imaging the bone marrow directly and of non-invasively assessing its composition. Normal age-related bone marrow changes, alterations related to red marrow reconversion, and pathological bone marrow processes generally conform to certain patterns that reflect the underlying marrow changes and can be clearly recognized on MR images. In addition to conventional pulse sequences, advanced MRI techniques such as Dynamic Contrast-Enhanced MRI and Diffusion-Weighted Imaging depict marrow changes at the microvascular and cellular level respectively. This book provides radiologists with in-depth information on the MRI appearances of normal, abnormal and treated marrow following a structured, pattern-based approach. MRI findings for various diseases that affect the bone marrow, particularly those of a malignant nature, are presented in detail. MRI pattern recognition not only offers a systematic approach to image interpretation and diagnosis but also has prognostic implications with regard to some disease entities. Each chapter includes a wealth of high-quality images, together with Key Points summarizing the most important information. In addition to radiologists, practitioners with an interest in hematology and oncology will find this textbook-atlas to be a valuable resource for the latest, clinically relevant advances in bone marrow imaging.
  • 2007 Springer
    contributors, M. Andreeff ... [et al.] ; editors, Katalin Kauser and Andreas-Michael Zeiher.
  • 2013 Springer
    Lars Kaestner.
    Summary -- Introduction -- Direct evidence - the digital approach -- Fluorescence-based visualisation -- Aequorin-based measurements -- Measurement of calcium transport across membranes -- Molecular biology based approaches -- Manipulation of calcium -- Calcium-induced function -- Calcium signalling in cardiac myocytes -- Calcium signalling in red blood cells -- Perspective -- Calcium Signalling Methodology -- Non-linear and ultra high-speed imaging for explorations of the murine and human heart -- A system for optical high resolution screening of electrical excitable cells -- Concepts for optical high content screens of excitable primary isolated cells -- A primary culture system for sustained expression of a calcium sensor in preserved adult rat ventricular myocytes -- Calcium imaging of individual erythrocytes: Problems and approaches -- Calcium Signalling in Cardiac Myocytes -- Reduced Cardiac L-Type Ca²+ Current in Cav€ ₂ -/- Embryos Impairs Cardiac Development and Contraction With Secondary Defects in Vascular Maturation -- Overexpression of junctin causes adaptive changes in cardiac myocyte Ca²+ signaling -- Remodelling of Ca²+ handling organelles in adult rat ventricular myocytes during longterm culture -- Functional and morphological preservation of adult ventricular myocytes in culture by sub-micromolar cytochalasin D supplement -- Calcium Signalling in Red Blood Cells -- The non-selective voltage-activated cation channel in the human red blood cell membrane: reconciliation between two conflicting reports and further characterisation -- Ion channels in the human red blood cell membrane: Their further investigation and physiological relevance -- Prostaglandin E₂ activates channelmediated calcium entry in human erythrocytes: An indication for a blood clot formation supporting process -- Functional NMDA receptors in rat erythrocytes -- Stimulation of human red blood cells leads to Ca²+-mediated intercellular adhesion -- Lysophospatidic acid induced red blood cell aggregation in vitro -- Regulation of phosphatidylserine exposure in red blood cells -- Cation Channels in Erythrocytes - Historical and Future Perspective.
  • 2014 Wiley
    edited by Syed A. Abutalib, MD, Assistant Director, Hematology and Hematopoietic Cell Transplantation, Midwestern Regional Medical Center, Cancer Treatment Centers of America, Zion, IL, USA, USA, Maurie Markman, MD, Senior Vice President of Clinical Affairs, National Director of Medical Oncology, Center, Cancer Treatment Centers of America, Clinical Professor of Medicine, Drexel University College of Medicine, Philadelphia, PA, USA.
    Section 1 Malignant hematology and hematopoietic cell transplantation -- Part 1 Acute lymphoblastic leukemia in adults -- Part 2 Acute myeloid leukemia in adults -- Part 3 Myelodysplastic syndromes and related disorders -- Part 4 Myeloproliferative neoplasms -- Part 5 Chronic lymphocytic and other leukemias -- Part 6 Hodgkin Lymphoma -- Part 7 Non-Hodgkin's lymphomas -- Part 8 Plasma cell neoplasms and related disorders -- Part 9 Special issues in hematology -- Part 10 Special issues in hematopoietic cell transplantation -- Section 2 Oncology -- Part 1 Central nervous system tumors -- Part 2 Head and neck cancers and thoracic malignancies -- Part 3 Breast cancer -- Part 4 Gastrointestinal oncology -- Part 5 Genitourinary oncology -- Part 6 Skin malignancies -- Part 7 Gynecological malignancies -- Part 8 Sarcomas -- Part 9 Multidisciplinary approach: consultation with surgical oncology team -- Part 10 Multidisciplinary approach: consultation with radiation oncology team -- Part 11 Hereditary cancer syndromes and genetic testing in oncology -- Part 12 Special issues in hematology and oncology.
  • 2010 Springer
    Øystein Bruserud, editor.
    Part I. Introduction.-- Chemokine system in experimental and clinical hematology / Oystein Bruserud, Astrid Olsnes Kittang.-- Part II. Experimental hematology.-- Chemokine decoy receptors: strucuture-function and biological properties / Raffaella Bonecchi, Benedetta Savino, Elena M. Borroni, Alberto Mantovani, Massimo Locati.-- Role of chemokines in the biology of natural killer cells / Azzram A. Maghazachi.-- Chemokines in angiogenesis / Anna Dimbert.-- Part III. Immunobiology of allogeneic stem cell transplantation.-- Genetic polymorphisms in the cytokine and chemokine systems: their possible importance in allogeneic stem cell transplantation / Jeurgen Loeffler, Michael Ok, Oliver C. Morton, Markus Mezger, Hermann Einsele.-- Chemokine system: a possible therapeutic target in acute graft versus host disease / Nicolai A. Kittan, Gerhard C. Hildebrandt.-- Homing in on acute graft vs. host disease: tissue-specific T regulatory and Th17 cells / Brian G. Engelhardt, James E. Crowe Jr.-- Part IV: Clinical hematology.-- Chemokine network in acute myelogenous leukemia: molecular mechanisms involved in leukemogenesis and therapeutic implications / Astrid Olsnes Kittang, Kimberley Hatfield, Kristoffer Sand, Hakon Reikvam, Oystein Bruserud.-- CXCR4 in clinical hematology / Gary Calandra, Gary Bridger, Simon Fricker.-- Immunobiology of herparin-induced thrombocytopenia / Per Morten Sandset.
    Also available: Print – 2010
  • 2016 Springer
    Rüdiger Hehlmann, editor.
  • 2010 Springer
    edited by Richard Greil, Lisa Pleyer, Viktoria Faber, Daniel Neureiter.
    This book comprises an in-depth view on the current knowledge of chronic clonal myeloid diseases. Special emphasis is laid on chronic myeloid leukaemia and a'classic' myeloproliferative disorders (essential thrombocythemia, polycythemia vera, and chronic idiopathic myelofibrosis) as well as myelodysplastic syndromes, oligoblastic leukemias, paroxysmal nocturnal hemoglobinuria and overlap diseases. Both young physicians in hematological training as well as practicing hematologists are addressed, with the aim of imparting a clear understanding of these disorders.
  • 2014 Springer
    Alexander V. Akleyev.
    This book covers all aspects of chronic radiation syndrome (CRS) based on observations in a unique sample of residents of the Techa riverside villages in the southern Urals who were exposed to radioactive contamination in the 1950s owing to releases of liquid radioactive wastes from Mayak Production Association, which produced plutonium for weapons. In total, 940 cases of CRS were diagnosed in this population and these patients were subjected to detailed analysis. The opening chapters address the definition and classification of CRS, epidemiology and pathogenesis, covering molecular and cellular mechanisms, radioadaptation, and the role of tissue reactions. The pathoanatomy of CRS during the development and recovery stages is discussed for all organ systems. Clinical manifestations of CRS at the different stages are then described in detail and the dynamics of hematopoietic changes are thoroughly examined. In the following chapters, principles of diagnosis (including assessment of the exposure doses to critical organs) and differential diagnosis from a wide range of other conditions are discussed and current and potential treatment options, described. The medical and social rehabilitation of persons with CRS is also covered. This book, which casts new light on the condition, will be of value for all practitioners and researchers with an interest in CRS.
  • 2011 Springer
    Peter B. Gahan, editor.
  • 2011 Springer
    Manfred Wick, Wulf Pinggera, Paul Lehmann ; with contributions by Volker Ehrhardt.
  • 2010
    [edited by] Shirlyn B. McKenzie, J. Lynne Williams.
    Status: Not Checked OutLane Catalog Record
  • 2008 Springer
    Alan List.
  • 2014 Springer
    Alan Lichtin, John Bartholomew, editors.
    There have been many changes in the field of coagulation during the past decade. New concepts of epidemiology of risk factors for thrombosis now help clinicians predict who is more likely to form clots after surgery, or after being placed on oral contraceptives. New anticoagulants have the potential to redefine how patients with atrial fibrillation and venous thrombosis are managed. There are new forms of recombinant clotting factors which have changed our approach to hypofibrinogenemia and von Willebrand's disease. Newer antiplatelet agents are available and their use in patients receiving cardiac stents has mushroomed. The management of thrombosis in the setting of pregnancy has changed over the past decade, as well as the way clinicians approach women with multiple miscarriages. An entire new class of compounds, the thrombopoietins, are available to treat individuals with immune thrombocytopenic purpura (ITP). The Coagulation Consult covers major topics of interest to hematologists who are asked to consult on individuals with coagulation related diseases, and encompasses the field's most recent developments. This "case-directed" book describes state-of-the-art approaches to patients with bleeding and clotting disorders, as well as laboratory tests for coagulation. Chapters include different vignettes, focus on typical clinical consult questions, and lay out specific types of treatment. Practicing clinicians being confronted with a coagulation consult, students, residents, fellows and attending physicians will find this unique text an invaluable resource for some of the newer areas of coagulation science, therapy and pharmacology.
  • 2009 Springer
    edited by David Green, Hau C. Kwaan.
    Also available: Print – 2009
  • 2010 ClinicalKey
    A. Victor Hoffbrand, John E. Pettit, Paresh Vyas.
    Cell machinery -- Cellular basis of hematopoiesis -- Growth factors -- Maturation of blood cells and their examination in peripheral blood and bone marrow -- Hypochromic anemias -- The porphyrias and iron overload -- Megaloblastic anemias -- Hemolytic anemias -- Genetic disorders of hemoglobin -- Benign disorders of phagocytes -- Benign disorders of lymphocytes -- Acute leukemias -- Chronic myeloid (myelogenous) leukemias and myelodysplastc/myeloproliferative neoplasms -- Myelodysplastic syndromes -- Myeloproliferative neoplasms -- Histiocytic disorders -- Aplastic and dyserythropoietic anemias -- Chronic lymphoid leukemias -- Non-Hodgkin lymphomas: mature B-cell neoplasms: written with professor Elias Campo -- Peripheral T-cell disorders -- Hodgkin lymphoma -- Myeloma and related conditions -- Tissue typing and stem cell treansplantation -- Vascular and platelet bleeding disorders -- The inherited and acquired coagulation disorders -- Thrombosis -- Secondary anemia and bone marrow in nonhematopoietic disorders -- Parasitic disorders -- Blood transfusion.
  • 2010 CRCnetBASE
    edited by C. Pozrikidis.
    "Preface Computational biofluiddynamics addresses a diverse family of problems involving fluid flow inside and around living organisms, organs and tissue, biological cells, and other biological materials. Numerical methods combine aspects of computational mechanics, fluid dynamics, computational physics, computational chemistry and biophysics into an integrated framework that couples a broad range of scales. The goal of this edited volume is to provide a comprehensive, rigorous, and current introduction into the fundamental concepts, mathematical formulation, alternative approaches, and predictions of computational hydrodynamics of capsules and biological cells. The book is meant to serve both as a research reference and as a teaching resource. Scope The numerical methods discussed in the following eight chapters cover a broad range of possible formulations for simulating the motion of rigid particles (platelets) and the flow-induced deformation of liquid capsules and cells enclosed by viscoelastic membranes. Although some of the physical problems discussed in different chapters are similar or identical, the repetition is desirable in that solutions produced by different numerical approaches can be compared and the efficiency of alternative formulations can be assessed. The consistency of the results validates the procedures and offers several alternatives"--Provided by publisher.
  • 2007 Springer
    edited by D.P. Berger ... [et al.].
  • 2013 ScienceDirect
    2013 ClinicalKey
    [edited by] Craig S. Kitchens, Craig M. Kessler, Barbara A. Konkle.
    The Consultative Process -- A Systematic Approach to the Bleeding Patient: Correlation of Clinical Symptoms and Signs with Laboratory Testing -- Endothelium -- Hemophilia A and B -- Less Common Congenital Disorders of Hemostasis -- Acquired Coagulation Disorders Caused by Inhibitors -- von Willebrand Disease -- General Aspects of Thrombocytopenia, Platelet Transfusions, and Thrombopoietic Growth Factors -- Primary Immune Thrombocytopenia -- Congenital and Acquired Disorders of Platelet Function and Number -- Purpura and Other Hematovascular Disorders -- Disseminated Intravascular Coagulation -- The Crosstalk of Inflammation and Coagulation in Infectious Disease and Their Roles in Disseminated Intravascular Coagulation -- Thrombophilia: Clinical and Laboratory Assessment and Management -- Pediatric Aspects of Thrombophilia -- Deep Vein Thrombosis and Pulmonary Embolism -- Venous Thromboses at Unusual Sites -- Postthrombotic Syndrome -- Thrombocytosis: Essential Thrombocythemia and Reactive Causes -- Antiphospholipid Syndrome: Pathogenesis, Clinical Presentation, Diagnosis, and Patient Management -- Hemostatic Aspects of Cardiovascular Medicine -- Nonarteriosclerotic Arterial Occlusive Disease -- Thrombosis and Cancer -- Thrombotic Thrombocytopenic Purpura and Related Thrombotic Microangiopathies -- Heparin-Induced Thrombocytopenia -- Antithrombotic Agents -- Blood Component and Pharmacologic Therapy for Hemostatic Disorders -- Thrombolytic Therapy -- Topical Hemostatic Agents -- Therapeutic Apheresis: Applications for Hemorrhagic and Thrombotic Disorders -- Use of Vena Cava Filters and Venous Access Devices -- Dietary Supplements and Hemostasis -- Thrombotic Risk of Contraceptives and Other Hormonal Therapies -- Bleeding and the Management of Hemorrhagic Disorders in Pregnancy -- Thrombophilia in Pregnancy -- Surgery and Hemostasis -- Anticoagulation in the Perioperative Period -- Understanding and Managing the Coagulopathy of Liver Disease -- Outpatient Anticoagulant Therapy -- Point-of-Care Hemostasis Testing -- Prevention and Treatment of Venous Thromboembolism in Neurologic and Neurosurgical Patients -- Hematologic Interventions for Acute Central Nervous System Disease -- Atrial Septal Abnormalities and Cryptogenic Stroke -- Pulmonary Hypertension: Thrombotic and Nonthrombotic in Origin -- Hemorrhage Control and Thrombosis Following Severe Injury -- Hemostatic Aspects of Sickle Cell Disease -- Anticoagulation for Atrial Fibrillation and Prosthetic Cardiac Valves.
  • 2014 Karger
    volume editors, Angela E. Thomas, Christina Halsey.
    Neonatal thrombocytopenia / Chakravorty, S.; Roberts, I. -- Pediatric and adolescent immune thrombocytopenia : prevention of bleeding versus burden of treatment / Cooper, N. -- Thrombosis in paediatrics : genetic versus environmental risk factors and implications for management / Monagle, P. -- Hematological problems in pediatric intensive care / Revel-Vilk, S.; Cox, P.; Robitaille, N.; Blanchette, V. -- New advances in the treatment of children with hemophilia / Lillicrap, D. -- Myelodysplastic and myeloproliferative diseases in children : current concepts / Vyas, P. -- Towards personalized medicine in childhood acute lymphoblastic leukaemia / Halsey, C. -- Reduced intensity conditioning in paediatric haematopoietic cell transplantation / Chiesa, R.; Veys, P. -- Can iron chelators replace stem cell transplantation in the treatment of thalassaemia syndromes? / Darbyshire, P.J. -- Iron deficiency : when and why oral iron may not be enough / Crary, S.E.; Buchanan, G.R. -- Principles of transitional care in haematology / Bolton-Maggs, P.; Choudhuri, S.
  • 2015 ScienceDirect
    edited by Catherine Stavropoulos-Giokas, Dominique Charron, Cristina Navarrete.
    Section I: Introduction. Introduction to cord blood stem cells / Dominique Charron, Catherine Stavropoulos-Giokas, Cristina Navarrete. Section II: Cord blood cells biology. Cord blood content / Gesine Kögler [and 3 others] -- Cord blood hematopoiesis : the road to transplantation / Anna Rita Migliaccio, Thalia Papayannopoulu -- Immunobiology of cord blood cells / Sergio Querol, Aurore Saudemont, Antoine Toubert -- Cord and cord blood-derived endothelial cells / Suzanne M. Watt [and 8 others] -- HLA and immunogenetics in cord blood transplantation / Dominique Charron, Emeline Masson, Pascale Loiseau. Section III: Cord blood cells for clinical use. Clinical use of umbilical cord blood cells / Robert Danby, Vanderson Rocha -- Immunodeficiencies and metabolic diseases / Paul J. Orchard, Angela R. Smith -- Cord blood cells and autoimmune diseases / LingYun Sun [and 3 others] -- Umbilical cord as a source of immunomodulatory reagents / Antonio Galleu, Francesco Dazzi -- Cord blood cells for clinical use : expansion and manipulation / Amanda L. Olson, Elizabeth J. Shpall -- Cord blood stem cells for clinical use : diabetes and cord blood / Yong Zhao -- Section IV: Regenerative medicine applications. Emerging uses of cord blood in regenerative medicine : neurological applications / Jessica M. Sun, Joanne Kurtzberg -- Biobanks for induced pluripotent stem cells and reprogrammed tissues / Lee Carpenter. Section V: Cord blood banking : a current state of affairs. Cord blood banking : operational and regulatory aspects / Cristina Navarrete -- Cord blood unit selection for unrelated transplantation / Andromachi Scaradavou -- Quality management systems including accreditation standards / Andreas Papassavas [and 6 others] -- Regulation across the globe / Maria Mitrossili [and 3 others] -- International development and import/export : WMDA / Lydia Foeken, Daniela Orsini. Section VI: Cord blood banking : current and future outlooks. Allogeneic and autologous cord blood banks / Paolo Rebulla -- The future of cord blood banks / Catherine Stavropoulos-Giokas [and 3 others]. Section VII: The viewpoint of society. An introductory note to the cord blood banking issues in a European and international environment / Marietta Giannakou -- Ethical and legal issues in cord blood stem cells and biobanking / Maria Mitrossili, Marcos Sarris, Yannis Nikolados -- Industrial economics of cord blood banks / Gregory Katz -- Public health policies in European Union : an innovation strategy : Horizon 2020 / Sotiris Soulis [and 5 others].
  • [2015?]
    Leo J. McCarthy.
    Status: Not Checked OutLane Catalog Record
    "Cryoprecipitate is still transfused although its genuine indications are specific and therefore, limited. Its accidental, yet fortuitous discovery by Dr. Judith Pool, and its clinical effectiveness subsequently established by Dr. Ed. Hershgold, enabled cryoprecipitate to quickly become the standard therapy for patients worldwide afflicted with hemophilia. However, its usage has declined since monoclonal factor VIII has emerged as the new standard of therapy primarily because of its lack of viral infectivity. Our expreience indicates it is frequently not transfused appropriately."--leaf 2.
  • 2007- Wiley
    editorial board, Thorsten Schlaeger (editor-in-chief), Roger Patient, Evan Snyder, Joseph Wu, Yukiko Yamashita ; past editors, Mick Bhatia, Andrew G. Elefany, Susan J. Fisher.
    Includes methods for isolating, maintaining, and differentiating embryonic and adult stem cells.
  • 2008 CRCnetBASE
    edited by N.K. Shinton.
    Also available: Print – 2008
  • v. 39, 2005. Springer
  • 2015 Springer
    Hannah Cohen, Patrick O'Brien, editors.
  • 2012 Springer
    Hannah Cohen, Patrick O'Brien, editors.
  • 2012 Springer
    Steven D. Mittelman, Nathan A. Berger, editors.
    The obesity pandemic continues to increase on a world-wide basis with over 70% of the United States population being either overweight or obese. Hematologic malignancies have recently been identified among the obesity associated malignancies spanning the lifespan from childhood to the elderly and include leukemia, myeloma, lymphoma and others. In addition to the etiologic association between obesity and hematologic malignancies, the presence of obesity has profound effects on therapy by impacting pharmacokinetics of chemotherapeutic agents, dose, adipocyte metabolism and drug distribution. These may be particularly important in hematopoietic stem cell transplantation. Another important aspect of the association of obesity with hematologic malignancies is the increased incidence of obesity in children who successfully complete therapy for acute lymphoblastic leukemia. This and other observations indicate important relations between the hematopoietic systems and fat metabolism. This volume on Energy Balance in Hematologic Malignancies will provide an important volume in this series and a basis for better understanding etiology, mechanisms, therapeutics implications and experimental approaches. This volume of energy balance and cancer will focus on the relation of obesity to hematologic malignancies, the epidemiology, potential mechanisms, and thereapeutic considerations including effects on pharmacologic and physical approaches as well as the delayed effects of therapy on energy balance.
  • 2006 Springer
    edited by G. Molineux, M.A. Foote, and S.G. Elliott.
  • 2014 Springer
    Yee Guan Yap, A John Camm.
    Atrial fibrillation (AF) affects an estimated 1?2% of the population and is the most common cause of sustained cardiac arrhythmia. Critically, the number of patients developing AF is expected to double in the next five decades, leading to increased incidence of stroke, heart failure and other serious thromboembolic events. Essentials of Atrial Fibrillation is a timely investigation of current pharmaceutical trends, clinical guidelines, novel treatments, and ongoing pipeline developments, including ground-breaking advances in the use of novel oral anticoagulants.
  • 2007 Karger
    volume editors, Detlev Schindler, Holger Hoehn.
    Why, what, and how can we learn from a rare disease like Fanconi anemia? / Schroeder-Kurth, T. -- Fanconi anemia: a disease with many faces / Dietrich, R., Velleuer, E. -- Milestones in Fanconi anemia research / Digweed, M., Hoehn, H., Sperling K. -- Fanconi anemia genes: structure, mutations, and genotype-phenotype correlations / Kalb, R. ... [et al.] -- Cancer in Fanconi anemia and Fanconi anemia genes in cancer / Neveling, K., Kalb, R., Schindler, D. -- Clonal chromosomal aberrations in bone marrow cells of Fanconi anemia patients: results and implications / Neitzel H. ... [et al.] -- Interphase FISH-assay for the detection of MDS- and AML-associated chromosomal imbalances in native bone marrow and peripheral blood cells / Tönnies, H. ... [et al.] -- Applications of cell cycle testing in Fanconi anemia / Schindler, D. ... [et al.] -- Prenatal diagnosis of Fanconi anemia: functional and molecular testing / Bechtold, A. ... [et al.] -- Revertant mosaicism in Fanconi anemia: natural gene therapy at work / Hoehn, H. ... [et al.] -- Stem cell transplantation in Fanconi anemia, recent advances with alternative donors / Eyrich, M., Winkler, B., Schlegel, P.G. -- Fanconi anemia genes in vertebrates: evolutionary conservation, sex-linkage, and embryonic expression of FANCC and FANCG in avian cells / Nanda, I. ... [et al.] -- Studying homologous recombination in Fanconi anemia / Demuth, I., Digweed, M. -- Functional knock-down of human RAD51 for testing the Fanconi anemia-BRCA connection / Rio, P., Hanenberg, H.
  • 2014 Springer
    Jean A. Klastersky, Consultant, Medical Oncology, Institut Jules Bordet, Centre des Tumeurs de l'Universite Libre de Bruxelles, Brussels, Belgium.
    1. Introduction -- 2. Prevention of febrile neutropenia -- 3. Prediction of the risk of complications associated with febrile neutropenia -- 4. Management of low-risk patients -- 5. Management of non-low-risk patients with febrile neutropenia -- 6. Management of persistent fever in patients with neutropenia despite empirical antibiotic administration -- 7. Costs associated with febrile neutropenia -- 8. At the extremes of age, febrile neutropenia in children and elderly
  • 2009 Springer
    Niranjan Bhattacharya, Phillip Stubblefield, editors.
  • 2010
    Agnieszka Czechowicz.
    Sickle Cell Anemia, Beta Thalassemia, Severe Combined Immunodeficiency (SCID), and Type I Diabetes share one commonality: these diverse disorders can all be attributed to faulty hematolymphoid effector cells which are largely caused by genetic mutations that alter hematopoietic cell-intrinsic function. These defective blood cells inherit their genetic deficiencies from hematopoietic stem cells (HSC) as they differentiate. Thus, each of these unique diseases should be theoretically curable through the same strategy: replacement of patients' HSCs carrying the problematic mutation with normal HSCs from disease-free donors, thereby generating entire new, healthy hematolymphoid systems. Replacement of disease-causing stem cells with healthy ones has been achieved clinically via hematopoietic cell transplantation (HCT) for the last 50 years, as a treatment modality for a variety of cancers and immunodeficiencies with moderate, but increasing success. However this technique bears high morbidity and mortality severely limiting its utilization. Purified hematopoietic stem cell transplantation is associated with high toxicity primarily attributed to the myeloablative pre-conditioning necessary to facilitate engraftment of the donor HSCs. However the function and mechanistic role of these reagents has been up until now poorly understood. This thesis deconstructs the current barriers in HCT and pure HSC transplantation, and suggests that in addition to the immune barrier, hematopoietic stem cell niche availability is another critical obstacle that needs to be overcome to allow for efficient hematolymphoid replacement. In this thesis I show that in the homeostatic state, most hematopoietic stem cell niches are occupied by host HSCs limiting the ability of incoming HSC engraftment. However, a limited number of HSC niches are vacated by HSC that are egressing from the peripheral blood into the bone marrow in a division independent manner, allowing for true but minimal HSC engraftment without myeloablative pre-conditioning. This thesis illustrates new, up-and-coming strategies to combat the obstacle of HSC niche availability. Here I prove that one non-myeloablative conditioning approach that capitalizes upon physiological HSC egress is repetitive transplantation of purified HSCs. However, this approach is rather laborious and inefficient, and I show that another more efficient novel non-myeloablative conditioning approach to vacate the HSC niche is antibody-mediated depletion of host HSCs. Furthermore, in this thesis I demonstrate that antibody-mediated inhibition of c-kit effectively depletes host HSCs and allows for efficient, non-toxic HSC transplantation. These novel non-myeloablative conditioning methods illustrate new means of overcoming the current barriers to hematolymphoid replacement thereby allowing for the potential expansion of this technique to treat a variety of inherited diseases of hematopoietic and immune function.
  • 2009 Springer Protocols
    edited by Christopher Baum.
    Immunomagnetic enrichment of human and mouse hematopoietic stem cells for gene therapy applications / Guillermo Guenechea, Jose C. Segovia, and Juan A. Bueren -- Isolation of human and mouse hematopoietic stem cells / Yuk Yin Ng ... [et al.] -- Murine hematopoietic stem cell transduction using retroviral vectors / Ute Modlich ... [et al.] -- Genetic modification of human hematopoietic cells: preclinical optimization of oncoretroviral-mediated gene transfer for clinical trials / Tulin Budak-Alpdogan and Isabelle Rivière -- Short-term culture of human CD34⁺ cells for lentiviral gene transfer / Francesca Santoni de Sio and Luigi Naldini -- T cell culture for gammaretroviral transfer / Sebastian Newrzela, Gunda Brandenburg, and Dorothee von Laer -- Retroviral transduction of murine primary T lymphocytes / James Lee, Michel Sadelain, and Renier Brentjens -- Lentiviral vector gene trasfer into human T cells / Els Verhoeyen, Caroline Costa, and Francois-Loic Cosset -- DNA transposons for modification of human primary T lymphocytes / Xin Huang ... [et al.] -- Retroviral gene transfer into primary human natural killer cells / Evran Alici, Tolga Sutlu, and M. Sirac Dilber -- Lentiviral vector-mediated genetic programming of mouse and human dendritic cells / Renata Stripecke -- In situ (in vivo) gene transfer into murine bone marrow stem cells / Dao Pan -- In vivo and ex vivo gene transfer in thymocytes and thymocyte precursors / Oumeya Adjali ... [et al.] -- Design and production of retro- and lentiviral vectors for gene expression in hematopoietic cells / Axel Schambach, William P. Swaney, and Johannes C.M. van der Loo -- Knock-down of gene expression in hematopoietic cells / Michaela Scherr, Letizia Venturiani, and Matthias Eder -- The use of retroviral vectors for tet-regulated gene expression in cell populations / Rainer Löw -- Detection of replication competent retrovirus and lentivirus / Lakshmi Sastry and Kenneth Cornetta -- Release testing of retroviral vectors and gene-modified cells / Diana Nordling, Anne Kaiser, and Lilith Reeves -- Copy number determination of genetically-modificed hematopoietic stem cells / Todd Schuesler ... [et al.] -- Tissue procurement for molecular studies using laser-assisted microdissection / Ulrich Lehmann and Hans Kreipe -- Leukemia diagnosis in murine bone marrow transplantation models / Zhixiong Li, Ute Modlich, and Anjali Mishra -- Humanized mouse models to study the human haematopoietic stem cell compartment / Dominique Bonnet -- Canine models of gene-modified hematopoiesis / Brian C. Beard and Hans-Peter Kiem -- Detection of retroviral integration sites by linear amplification-mediated PCR and tracking of individual integration clones in different samples / Manfred Schmidt ... [et al.] -- Retroviral insertion site analysis in dominant haematopoietic clones / Olga S. Kustikova, Ute Modlich, and Boris Fehse -- Tracking gene-modified T cells in vivo / Alessandra Recchia and Fulvio Mavilio -- DNA microarray studies of hematopoietic subpopulations / Karin Pike-Overzet ... [et al.] -- Quantification of genomic mutations in murine hematopoietic cells / Hartmut Geiger ... [et al.] -- Proteomics studies after hematopoietic stem cell transplantation / Eva M. Weissinger, Petra Zürbig, and Arnold Ganser -- Spectral karyotyping and fluorescence in situ hybridization of murine cells / Cornelia Rudolph and Brigitte Schlegelberger -- Database setup for preclinical studies of gene-modified hematopoiesis / Brenden Balcik, Elke Grassman, and Lilith Reeves -- The US and EU regulatory perspectives on the clinical use of hematopoietic stem/progenitor cells genetically modified ex vivo by retroviral vectors / Carolyn A. Wilson and Klaus Cichutek.
  • 2006 Springer
    T. Honjo and F. Melchers (eds.).
    Role of innate immune system and host-commensal mutualism / S. Rakoff-Nahoum and R. Medzhitov -- Molecular networks orchestrating GALT development / D. Finke and D. Meier -- Lymphoid tissue inducer cells in intestinal immunity / I.I. Ivanov, G.E. Diehl, and D.R. Littman -- Specificity and plasticity of memory lymphocyte migration / J. Rodrigo Mora and U.H. von Adrian -- IgA adaptation to the presence of commensal bacteria in the intestine / A. J. Macpherson -- Intestinal IgA synthesis : a primitive form of adaptive immunity that regulates microbial communities in the gut / S. Fagarasan -- B cell recruitment and selection in mouse GALT germinal centers / S. Casola and K. Rajewsky -- Structural insights into antibody-mediated mucosal immunity / A.E. Hamburger, P.J. Bjorkman, and A.B. Herr.
    Also available: Print – 2006
  • 2013 ClinicalKey
    Martin R. Howard, Peter J. Hamilton ; illustrated by Robert Britton.
    This textbook on haematology in the Illustrated Colour Text series is suitable for medical students, junior doctors and others needing a concise and practical introduction to the subject. Concise and manageable coverage of the major blood diseases and their treatment. Does not overload the reader with science, unlike some competing books. Focus is on the haematology patient and on the practical aspects of the subject. Makes use of the attractive features of the ICT series - double page spreads, lots of colour illustrations, summary boxes.
  • 2012 Wiley
    [edited by] Marvelle Brown, Tracey J. Cutler.
    Understanding haemopoiesis -- Immunology -- Genes and haematology -- The cell -- Aplastic anaemia : pathophysiology, care, and management -- Nutritional anaemia : pathophysiology, care, and management -- Acquired anaemia : pathophysiology, care, and management -- Inherited anaemia : pathophysiology, care, and management -- Sickle cell disease and thalassaemia : pathophysiology, care, and management -- Haemochromatosis : pathophysiology, care, and management -- Polycythemia : pathophysiology, care, and management -- The myelodysplastic syndromes : pathophysiology, care, and management -- Acute leukaemia : pathophysiology, care, and management -- Chronic leukaemia : pathophysiology, care, and management -- Multiple myeloma : pathophysiology, care, and management -- Lymphoma : pathophysiology, care, and management -- Blood transfusion -- Venous access devices -- Chemotherapy and monoclonal antibodies -- Haemopoietic stem cell transplant -- Palliative care.
  • 2013 Springer Protocols
    edited by Paul Monagle.
    Coagulation system in humans / Anthony K.C. Chan and Nethnapha Paredes -- Platelet physiology / Matthew D. Linden -- Role of the vessel wall / Nethnapha Paredes and Anthony K.C. Chan -- Specimen requirements for the haemostasis laboratory / Linda J. Stang and Lesley G. Mitchell -- Methods of coagulation / Gemma Crighton -- Reference ranges of coagulation tests / Oliver Speer [and others] -- Lupus anticoagulant testing / Karen Moffat, Anne Raby, and Mark Crowther -- Activated partial thromboplastin time / Vera Ignjatovic -- Prothrombin time/international normalized ratio / Vera Ignjatovic -- Thrombin clotting time / Vera Ignjatovic -- Thrombin generation / Leslie R. Berry and Anthony K.C. Chan -- Activated clotting time (ACT) / Stephen Horton and Simon Augustin -- Factor XIII assays / Stephen Opat [and others] -- Fibrinogen / Linda J. Stang and Lesley G. Mitchell -- Platelet counting / Sylvain Salignac [and others] -- Platelet morphology analysis / Véronique Latger-Cannard [and others] -- Light transmission aggregometry / Juan Pablo Frontroth -- Platelet flow cytometry / Matthew D. Linden -- Anti-factor Xa (Anti-Xa) assay / Fiona Newall -- Reptilase time (RT) / Hratsch Karapetian -- Protamine titration / Fiona Newall -- Laboratory methods for the assay of tissue factor pathway inhibitor in human plasma / Robyn Summerhayes -- Heparin-induced thrombocytopenia / Andreas Greinacher, Birgitt Fürll, and Sixten Selleng -- Nijmegen-Bethesda assay to measure factor VIII inhibitors / Elizabeth Duncan, Margaret Collecutt, and Alison Street -- Kaolin clotting time / Kottayam Radhakrishnan -- Dilute Russell's viper venom time / Kottayam Radhakrishnan -- Platelet neutralization test / Kottayam Radhakrishnan -- Antithrombin / Mirta Hepner and Vasiliki Karlaftis -- Protein C / Mirta Hepner and Vasiliki Karlaftis -- Protein S / Mirta Hepner and Vasiliki Karlaftis -- Testing for hyperhomocysteinemia in subjects with a history of thromboembolic events using HPLC technique / Jonas Denecke -- Anticardiolipin antibody and anti-beta 2 glycoprotein I antibody assays / Anne Raby, Karen Moffat, and Mark Crowther -- Testing for apolipoprotein(a) phenotype using isoelectric focusing and immunoblotting technique / Claus Langer, Bertram Tambyrayah, and Ulrike Nowak-Göttl -- D-dimer and fibrinogen/fibrin degradation products / Linda J. Stang.
  • 2015 Thieme eNeurosurgery
    2015 Thieme-Connect
    [edited by] Mark G. Hamilton, John G. Golfinos, Graham F. Pineo, William T. Couldwell.
  • 2013 Springer
    Ashfaq Hasan.
    Gas Exchange -- The Non-Invasive Monitoring of Blood Oxygen and Carbon Dioxide Levels -- Acids and Bases -- Buffer Systems -- pH -- Acidosis and Alkalosis -- Respiratory Acidosis -- Respiratory Alkalosis -- Metabolic Acidosis -- Metabolic Alkalosis -- The Analysis of Blood Gases -- Factors Modifying the Accuracy of ABG Results -- Case Examples.
  • 2014 Springer
    Timothy P Hughes, David M Ross, Junia V Melo.
    This concise, clinically focused pocket handbook assembles and synthesizes the latest developments and trends in the diagnosis and treatment of CML and provides an authoritative and convenient summary of the latest progress in TKI trials, the molecular monitoring of CML responses, and the development of new therapies to overcome resistance and improve patient care. Chronic myeloid leukemia (CML) is a rare type of leukemia (1?2 per 100,000 people) but is the most common chronic myeloproliferative neoplasm. CML remains a key model for the improved understanding of the pathophysiology of a malignancy at a molecular level; CML was the first cancer to be associated with a recurring chromosome abnormality, which generates the Philadelphia (Ph) chromosome and its associated fusion gene BCR-ABL1. The clinical outcome for patients with CML has changed dramatically in the past 15 years and this has been due to the development of tyrosine kinase inhibitors (TKIs), compounds that inhibit the activity of the oncogenic BCR-ABL1 protein. A number of first-, second- and third-generation TKIs are now available for the treatment of CML, although a number of treatment challenges remain, not least the development of treatment-resistant CML. Parallel to the development of specific drugs for treating CML, major advances have been made in the field of disease monitoring and standardization of response criteria.
  • 2015 Springer
    Mohamad Mohty, Jean-Luc Harousseau, editors.
    This handbook is an in-depth and comprehensive guide to the pathophysiology, diagnosis, staging, treatment and management of patients with multiple myeloma. The Handbook was commissioned to address an unmet need for a book of this kind in the myeloma field and to provide busy healthcare professionals with an informative and educational review of the current and emerging treatment recommendations for multiple myeloma. Myeloma is a type of bone marrow cancer arising from plasma cells and is the second most common form of bone marrow cancer, but represents just 1% of all cancers. The causes of myeloma are not fully understood but it is thought to be caused by an interaction of both genetic and environmental factors. This Handbook discusses these issues as well the latest developments in the field and will be an invaluable source of topical information for all healthcare professionals with an interest in multiple myeloma.
  • 2009 CRCnetBASE
    edited by Valery V. Tuchin.
    "This handbook presents methods that improve the accuracy in glucose prediction based on infrared absorption spectroscopy, recent studies on the influence of acute hyperglycemia on cerebral blood flow, and the correlation between diabetes and the thermo-optical response of human skin. It examines skin glucose monitoring by near-infrared spectroscopy (NIR), fluorescence-based glucose biosensors, and a photonic crystal contact lens sensor. The contributors also explore problems of polarimetric glucose sensing in transparent and turbid tissues as well as offer a high-resolution optical technique for noninvasive, continuous, and accurate blood glucose monitoring and glucose diffusion measurement."--BOOK JACKET.
  • 2013 Springer
    editors: Gregory YH Lip, Eduard Shantsila ; contributors: Deirdre A. Lane...[and more].
    This book covers a wide range of disorders such as atrial fibrillation, artificial heart valves, deep vein thrombosis, pulmonary embolism and stroke. Handbook of Oral Anticoagulation aims to provide an accessible overview of the exciting new developments in this field. Incorporating numerous quick-reference tables and figures and fully referenced throughout to key papers and the latest reviews, it will be a useful resource for all healthcare professionals involved in thromboprophylaxis.
  • 2010 Springer
    Gregory Y H Lip, Eduard Shantsila ; with contributions from Deirdre A. Lane...[et al.].
    The coagulation pathway and approaches to anticoagulation -- Common clinical indications for anticoagulation -- The vitamin K antagonists and their limitations -- Haemorrhage risks, patient perspectives, and quality-of-life issues -- New oral anticoagulants -- Future directions.
  • 2012 Wiley
    Caroline A. Hastings, Joseph C. Torkildson, Anurag K. Agrawal.
    1. Approach to the Anemic Child -- 2. Hemolytic Anemia -- 3. Sickle Cell Disease -- 4. Thalassemia -- 5. Transfusion Medicine -- 6. Chelation Therapy -- 7. Approach to the Bleeding Child -- 8. Von Willebrand Disease -- 9. Hemophilia -- 10. The Child with Thrombosis -- 11. The Neutropenic Child -- 12. Thrombocytopenia -- 13. Evaluation of the Child with a Suspected Malignancy -- 14. Oncologic Emergencies -- 15. Acute Leukemias -- 16. Central Nervous System Tumors -- 17. Hodgkin and Non-Hodgkin Lymphoma -- 18. Wilms Tumor -- 19. Neuroblastoma -- 20. Sarcomas of the Soft Tissues and Bone -- 21. Germ Cell Tumors -- 22. Rare Tumors of Childhood -- 23. Histiocytic Disorders -- 24. Hematopoietic Stem Cell Transplantation -- 25. Supportive Care of the Child with Cancer -- 26. Central Venous Catheters -- 27. Management of Fever in the Child with Cancer -- 28. Acute Pain Management in the Inpatient Setting -- 29. Palliative Care -- 30. Chemotherapy Basics -- 31. Guide to Procedures -- 32. Treatment of Chemotherapy Extravasations.
  • 2011 Springer
    by David Warwick, David Gozzard ; David Perry (editor).
    Introduction -- Thromboprophylaxis in medical patients -- Pharmacoeconomics of medical thromboprophylaxis -- Introduction to thromboprophylaxis in surgical patients -- Thromboprophylaxis in orthopaedic surgery -- Thromboprophylaxis in cancer surgery -- Thromboprophylaxis in other types of surgery -- Thromboprophylaxis in patients on oral anticoagulant therapy -- The pharmacoeconomics of surgical thromboprophylaxis -- Thromboprophylaxis in pregnancy.
  • 2012 Springer
    Jianguo Tao, Eduardo Sotomayor, editors.
    B Cell Growth, Differentiation and Malignancies / Jianguo Tao and Chih-Chi Andrew Hu -- Follicular Lymphoma: Recent Advances / Alyssa Bouska, SharathKumar Bagvati, Javeed Iqbal, Basem M. William and Wing C. Chan -- Chronic Lymphocytic Leukemia: From Pathobiology to Targeted Therapy / Javier Pinilla-Ibarz and Chih-Chi Andrew Hu -- Genetic and Environmental Determinants in Multiple Myeloma: Implications for Therapy / Kenneth H. Shain and William S. Dalton -- EBV-Positive Diffuse Large B-Cell Lymphoma of the Elderly / Jorge J. Castillo -- HIV and Lymphoma / Lubomir Sokol and Brady E. Betran -- Molecular Biology of Mantle Cell Lymphoma / Bijal Shah, Peter Martin, Jianguo Tao and Eduardo M. Sotomayor -- Pathogenesis of Non-Hodgkin Lymphoma Derived from Inflammatory, Autoimmune or Immunologic Disorders / Ling Zhang and Jianguo Tao -- Pathogenesis of Non-Hodgkin Lymphoma Derived from Infection Diseases / Ling Zhang and Roger Klein -- Hodgkin Lymphoma: From Molecular Pathogenesis to Targeted Therapy / Ádám Jóna, Árpád Illés and Anas Younes -- Myelodysplastic Syndromes / Grant E. Nybakken and Adam Bagg -- Chronic Myeloproliferative Disorders:From Molecular Pathogenesis to Targeted Therapy / Richard A. Walgren and Josef Prchal -- Chronic Myeloid Leukemia / Kapil Bhalla, Celalettin Ustun and Warren Fiskus -- Novel Targeted Therapeutics for Acute Myeloid Leukemia / Vu Duong and Jeffrey Lancet -- Novel Targeted Therapeutics for Peripheral T-Cell Lymphoma / Owen O. Connor, Salvia Jain and Jasmine Zain -- Large Granular Lymphocyte Leukemia - From Molecular Pathogenesis to Targeted Therapy / Mithun Vinod Shah and Thomas P. Loughran Jr. -- Epigenetic Regulation and Therapy in Lymphoid Malignancies / Yizhuo Zhang, Shanqi Guo and Haifeng Zhao.
  • 2008 Springer
    [edited by] E.H. Estey, S.H. Faderl, H.M. Kantarjian.
    Also available: Print – 2008
  • 2007 Springer
    J.V. Melo, J.M. Goldman, [editors].
  • 2006 Springer
    H.J. Deeg [edited by] ... [et al.].
    Also available: Print – 2006
  • 2015 Springer
    Giorgio Berlot, Gabriele Pozzato, editors.
    This book covers a wide array of hematologic problems commonly encountered in the daily practice of critical care and emergency medicine. Unfortunately, the symptoms and signs associated with underlying hematologic disorders are frequently rather unspecific and confounding; furthermore, the clinical course of patients admitted to intensive care units with such disorders can be fulminant, warranting prompt diagnosis. This book recognizes the importance of accurate and speedy interpretation of symptoms in that the text is symptom oriented rather than disease oriented. Put another way, the reader confronted with a particular clinical problem or symptom will be guided step by step to the possible underlying disorder(s). The scenarios considered include critical illness in patients with anemia, leukopenia, leukocytosis, abnormal platelet count, and severe transfusion reactions. For each circumstance, factors relevant to symptom interpretation are fully discussed. In addition, helpful diagnostic algorithms are presented in the form of flow charts that will assist in decision making regarding the need for further investigations. The closing chapter is devoted to the drug-induced hematologic disorders. Although the book is intended mainly for intensivists, other specialists will find much information of value for their daily practice.
  • 2013 Springer Protocols
    edited by Magdalena Czader.
    Quantitative BCR-ABL1 RQ-PCR fusion transcript monitoring in chronic myelogenous leukemia / Franklin R. Moore, Carole B. Rempfer, and Richard D. Press -- Detection of BCR-ABL1 kinase domain mutations causing imatinib resistance in chronic myelogenous leukemia / Franklin R. Moore, Fei Yang, and Richard D. Press -- Laboratory detection of JAK2 V617F in human myeloproliferative neoplasms / Jonathan S. Kui, Rosanny Espinal-Witter, and Y. Lynn Wang -- c-kit Mutational analysis in paraffin material / Karl Sotlar -- Detection of recurrent cytogenetic abnormalities in acute lymphoblastic and myeloid leukemias using fluorescence in situ hybridization / Gail H. Vance -- Liquid bead array technology in the detection of common translocations in acute and chronic leukemias / Rodney E. Shackelford [and others] -- Molecular genetic tests for FLT3, NPM1, and CEBPA in acute myeloid leukemia / Qing Zhang, Shaochun Bai, and Gail H. Vance -- Flow cytometric monitoring of residual disease in acute leukemia / Brent L. Wood -- Chimerism analysis following hematopoietic stem cell transplantation / Kathleen M. Murphy -- Detection of clonal immunoglobulin heavy chain gene rearrangements by the polymerase chain reaction and capillary gel electrophoresis / Hongxin Fan and Ryan S. Robetorye -- Detection of clonal T-cell receptor beta and gamma chain gene rearrangement by polymerase chain reaction and capillary gel electrophoresis / Hongxin Fan and Ryan S. Robetorye -- Detection of genetic translocations in lymphoma using fluorescence in situ hybridization / Kaaren K. Reichard and Sheldon Robinett -- Molecular detection of t(14;18)(q32;q21) in follicular lymphoma / C. Cameron Yin and Rajyalakshmi Luthra -- Molecular detection of t(11;14)(q13;q32) in mantle cell lymphoma / C. Cameron Yin and Rajyalakshmi Luthra -- Detection of t(2;5)(p23;q35) in anaplastic large-cell lymphoma by long-range nested polymerase chain reaction assay / C. Cameron Yin and Rajyalakshmi Luthra -- EBER in situ hybridization for Epstein-Barr virus / Lawrence M. Weiss and Yuan-Yuan Chen -- Epstein-Barr virus (EBV) load determination using real-time quantitative polymerase chain reaction / Hongxin Fan and Ryan S. Robetorye -- Molecular and immunohistochemical detection of kaposi sarcoma herpesvirus/human herpesvirus-8 / Amy Chadburn, Janet Wilson, and Y. Lynn Wang -- Detection of cytomegalovirus infection by quantitative polymerase chain reaction / Magdalena Czader, Kristin Post, and Liang Cheng -- Thiopurine S-methyltransferase pharmacogenetics in childhood acute lymphoblastic leukemia / Jun J. Yang and Deepa Bhojwani -- MicroRNA expression profiling using microarrays / Cassandra Love and Sandeep Dave.
  • v. 1-<4>, 1979-<1986>
    Robert M. Schmidt, section editor.
    Status: Not Checked OutLane Catalog Record
  • 2009
    [edited by] Ronald Hoffman ... [et al.].
    Status: Not Checked OutLane Catalog Record
  • 2013 ClinicalKey
    [edited by] Ronald Hoffman, Edward J. Benz, Jr., Leslie E. Silberstein, Helen E. Heslop, Jeffrey I. Weitz, John Anastasi.
  • 2012 ClinicalKey
    S. David Hudnall.
    Hematology: A Pathophysiologic Approach, by S. David Hudnall, MD, FCAP, delivers an accessible yet thorough understanding of hematolymphoid physiology and pathophysiology. This new title in the Mosby Physiology Monograph Series offers you masterful explanations of hematopoiesis, immunology, hemostasis, hemoglobinopathy, metabolic disorders, genetics, and neoplasia from an authority who has 26 years of practical experience in laboratory hematology and has taught thousands of medical and undergraduate students. In print and online at, this is an ideal integrated, problem-based way to learn about this complex subject. Receive masterful explanations of hematopoiesis, immunology, hemostasis, hemoglobinopathy, metabolic disorders, genetics, and neoplasia from S. David Hudnall, MD, FCAP, who has 26 years of practical experience in laboratory hematology and has taught thousands of medical and undergraduate students. Understand the interrelationships between the diverse factors that can give rise to disease. See how hematologic disorders are evaluated through blood counting, histopathology, immunohistochemistry, cytogenetics, and coagulation testing. Visualize a wide spectrum of hematologic pathology by viewing 150 full-color photomicrographs. Access the complete contents online at
  • 2015 ScienceDirect
    Amer Wahed, Amitava Dasgupta.
  • v. 1, 1973.
    by John B. Harley, Sundaram V. Ramanan and Mabel M. Stevenson.
    Status: Not Checked OutLane Catalog Record
  • 2012 ScienceDirect
    2012 ClinicalKey
    [edited by] Robin K. Ohls, Akhil Maheshwari ; consulting editor, Richard A. Polin.
    Updated information on stem cells for the neonatologist -- Current issues in the pathogenesis, diagnosis, and treatment of neonatal thrombocytropenia -- Role of recombinant leukocyte colony-stimulating factors in the neonatal intensive care unit -- Nonhematopoietic effects of erythropoietin -- Why, when, and how should we provide red cell transfusions and erythropoiesis-stimulating agents to support red cell mass in neonates? -- Diagnosis and treatment of immune-mediated and non-immune-mediated hemolytic disease of the newborn -- Hematology and immunology: coagulation disorders -- A practical approach to the neutropenic neonate -- What evidence supports dietary interventions to prevent infant food hypersensitivity and allergy? -- Maternally mediated nenonatal autoimmunity -- CMV: diagnosis, treatment, and considerations on vaccine-mediated prevention -- Neonatal T cell immunity and its regulation by innate immunity and dendritic cells -- Breast milk and viral infection -- Probiotics for the prevention of necrotizing enterocolitis in preterm neonates -- The ureplasma conundrum: should we look or ignore? -- Control of antibiotic-resistant bacteria in the neonatal intensive care unit -- Neonatal fungal infections -- The use of biomarkers for detection of early-and late-onset neonatal sepsis -- Chorioamnionitis and its effects on the fetus/neonate: emerging issues and controversies.
  • 2011
    Robert S. Hillman [and others].
    Status: Not Checked OutLane Catalog Record
    Normal erythropoiesis -- Clinical approach to anemia -- Marrow-damage anemia -- Anemias associated with a reduced erythropoietin response -- Iron-deficiency anemia -- Thalassemia -- Hemoglobinopathies -- Macrocytic anemias -- The dysplastic and sideroblastic anemias -- Blood loss anemia -- Hemolytic anemias -- Anemia in the elderly -- Erythrocytosis and polycythemia vera -- Disorders of porphyrin metabolism -- Hemochromatosis -- Normal myelopoiesis -- Quantitative and qualitative disorders of neutrophils -- The acute myeloid leukemias -- Chronic myelogenous leukemia and the myeloproliferative disorders -- Normal lymphopoiesis and the lymphatic system -- Lymphopenia and immune deficiency -- Chronic lymphocytic leukemia and other leukemic lymphoproliferative diseases -- Non-Hodgkin lymphomas -- Hodgkin lymphoma -- Acute lymphocytic leukemia -- Plasma cell disorders -- Monocyte-macrophage disorders -- Normal hemostasis -- Clinical approach to bleeding disorders -- Vascular purpura -- Thrombocytopenia -- Platelet dysfunction and von Willebrand disease -- Hemophilia and other intrinsic pathway defects -- Extrinsic and common pathway coagulopathies -- Consumptive coagulopathies -- Thrombotic disorders -- Anticoagulation in the management of thrombotic disorders -- Blood component therapy.
  • 2014 ScienceDirect
    Anika Niambi Al-Shura ; medical illustrator, Samar Sobhy.
  • 2013 ClinicalKey
    [edited by] Jon C. Aster, Olga Pozdnyakova, Jeffrey L. Kutok.
  • 2010 Springer
    [edited by] Domnita Crisan.
    Molecular techniques in hematopathology / Bobby L. Boyanton Jr. and Jennifer R. Rushton -- Classical and molecular cytogenetic analysis of hematolymphoid disorders / Mark A. Micale -- Using cytogenetic and molecular tests in diagnostic workups with the WHO classification - 2008 / Clarence C. Whitcomb -- Update on the molecular pathology of precursor lymphoid leukemias / Robert B. Lorsbach -- Molecular pathology of acute myeloid leukemias / Karen P. Mann and Debra F. Saxe -- Molecular pathology of mature B-cell and T-cell lymphomas / Sophia L. Yohe, David W. Bahler, and Marsha C. Kinney -- Molecular pathology of myeloproliferative neoplasms / David S. Bosler -- Molecular pathology of chronic lymphocytic leukeumia / Daniela Hoehn, L. Jeffrey Medeiros, and Sergj Konoplev -- Targeted therapy in hematologic malignancies / Barbara Zehnbauer and Mona Nasser -- Micro-RNAs in hematologic malignancies / Muller Fabbri and George A. Calin.
  • 2008 ScienceDirect
    Faramarz Naeim, P. Nagesh Rao, Wayne W. Grody.
  • 2012 ClinicalKey
    edited by Eric D. Hsi.
    Section 1. Non-neoplastic disorders -- section 2. Lymphomas -- section 3. Leukemias, chronic myeloproliferative neoplasms, and myelodysplasia -- section 4. Disorders of histiocytes, mast cells, plasma cells, spleen, and ancillary techniques.
  • 2017 ClinicalKey
    [edited by] Elaine S. Jaffe, Daniel A. Arber, Elias Campo, Nancy Lee Harris, Leticia Quintanilla-Martinez.
    Processing of the lymph node biopsy specimen -- Fine needle aspiration of lymph nodes -- Collection, processing, and examination of bone marrow specimens -- Immunohistochemistry for the hematopathology laboratory -- Flow cytometry -- Molecular diagnosis in hematopathology -- Important chromosomal aberrations in hematologic neoplasms and key techniques to diagnose them -- Normal lymphoid organs and tissues -- Reactive lymphadenopathies -- Normal bone marrow -- Evaluation of anemia, leukopenia, and thrombocytopenia -- Bone marrow findings in inflammatory, infectious, and metabolic disorders -- Principles of classification of lymphoid neoplasms -- B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma, monoclonal B-cell lymphocytosis, and B-cell prolymphocytic leukemia -- Lymphoplasmacytic lymphoma and Waldenström macroglobulinemia -- Hairy cell leukemia -- Splenic marginal-zone lymphoma and other small B-cell neoplasms in the spleen -- Follicular lymphoma -- Extranodal marginal zone lymphoma : malt lymphoma -- Primary cutaneous B-cell lymphomas -- Nodal marginal zone lymphoma -- Mantle cell lymphoma -- Diffuse large B-cell lymphoma -- Burkitt's lymphoma and its mimics -- Plasmablastic neoplasms other than plasma cell myeloma -- Plasma cell neoplasms -- Nodular lymphocyte-predominant Hodgkin's lymphoma -- Classical Hodgkin's lymphoma and related lesions -- Virally associated B-cell lymphoproliferative disease -- Virally associated T-cell and NK-cell neoplasms -- T-cell and NK-cell large granular lymphocyte proliferations -- T-cell prolymphocytic leukemia -- Adult T-cell leukemia/lymphoma -- Hepatosplenic T-cell lymphoma -- Peripheral T-cell lymphoma, not otherwise specified -- Angioimmunoblastic T-cell lymphoma -- Anaplastic large cell lymphoma, ALK positive and ALK negative -- Enteropathy-associated T-cell lymphoma and other primary intestinal T-cell lymphomas -- Mycosis fungoides and Sézary syndrome -- Primary cutaneous CD30-positive T-cell lymphoproliferative disorders -- Primary cutaneous T-cell lymphomas : rare subtypes -- Precursor b- and T-cell neoplasms -- Acute leukemias of ambiguous lineage -- Principles of classification of myeloid neoplasms -- Myelodysplastic syndromes -- Acute myeloid leukemia -- Myeloproliferative neoplasms -- Myelodysplastic/myeloproliferative neoplasms -- Mastocytosis -- Eosinophilia and chronic eosinophilic leukemia, including myeloid/lymphoid neoplasms with eosinophilia and rearrangement of PDGFRA, PDGFRB, FGFR1 , OR JAK2 -- Blastic plasmacytoid dendritic cell neoplasm -- Non-neoplastic histiocytic proliferations of lymph nodes and bone marrow -- Histiocytic and dendritic cell neoplasms including Langerhans cell histiocytosis and Langerhans cell sarcoma -- The pathology of primary immunodeficiencies -- Iatrogenic immunodeficiency-associated lymphoproliferative disorders -- Bone marrow evaluation for lymphoma -- Evaluation of the bone marrow after therapy -- Non-hematopoietic neoplasms of the bone marrow -- Non-lymphoid lesions of the lymph nodes -- Spleen : normal architecture and neoplastic and non-neoplastic lesions -- Diagnosis of lymphoma in extranodal sites other than skin.
  • 2014 Springer
    [edited by] Franklin O. Smith, Gregory H. Reaman, Judy M. Racadio.
  • 2011 Springer
    Gary H. Lyman, David C. Dale, editors.
    Part 1. Background: Biology, Physiology and Pharmacology -- Part 2. The Colony-Stimulating Factors -- Part 3. The Erythroid-Stimulating Agents -- Part 4. The Thrombopoietic Agents -- Part 5. Special Considerations.
    Also available: Print – 2011
  • 2006 Springer
    [edited by] Isabelle Godin, Ana Cumano.
    Origin and fate of hematopoietic precursors in the early mouse embryo / Julien Yuan Bertrand ... [et al.] -- Hematopoietic development in drosophila: a parallel with vertebrates / Marie Meister and Shubha Govind -- Intraembryonic development of hematopoietic stem cells during human ontogeny: expression analysis / Caroline Marshall -- Gene and cell therapy involving hematopoietic stem cell / Isabelle André-Schmutz and Marina Cavazzana-Calvo. Ventral and dorsal contributions to hematopoiesis in xenopus / Aldo Ciau-Uitz, Maggie Walmsley and Roger Patient -- Genetic dissection of hematopoiesis using the zebrafish / Rebecca A. Wingert and Leonard I. Zon -- Extra- and intraembryonic HSC commitment in the avian model / Thierry Jaffredo ... [et al.] -- Avian lymphopoiesis and transcriptional control of hematopoietic stem cell differentiation / Jussi Liippo and Olli Lassila -- Yolk sac development in mice / James Palis -- Long-term reconstituting hematopoietic stem cell capacity in the embryo / Mervin C. Yoder -- The endothelium: the cradle of definitive hematopoiesis? / Katrin Ottersbach and Elaine Dzierzak -- Endothelial and hematopoietic cells in the intraembryonic compartment / Fumio Arai and Toshio Suda --
    Also available: Print – 2006

Access restricted to Stanford community

Shortcut to Licensed Content

Lane Gateway to Licensed Content

TO INSTALL, DRAG THIS BUTTON to your browser Bookmarks or Tools Bar.

What is it?

Lane Gateway to Licensed Content

Bookmark on Other Websites

Bookmark on Lane

  • TO INSTALL, RIGHT CLICK this button.
  • Select "Add to Favorites" (click “Continue” if you see a security alert)
  • From the "Create in" menu, select “Favorites Bar” (IE8, IE9) to install
  • Once installed it will look like this
  • Click "Bookmark on Lane" to bookmark any webpage
  • Your saved bookmark will appear on this page

What is it?

A repository of medical knowledge from internal medicine, cardiology, genetics, pharmacy, diagnosis and management, basic sciences, patient care, and more.

Continuously expanding, all databases in the repository contain the latest editions of selected medical titles.

MicroMedex: Premier pharmaceutical information source containing multiple databases and drug reference tools. Of particular value is DRUGDEX Evaluations, one of the most comprehensive drug sources available.DynaMed Plus is a clinical information resource used by physicians to answer clinical questions quickly and easily at the point of care. Topics are updated daily as new evidence becomes available.Scopus is the largest abstract and citation database of peer-reviewed literature: scientific journals, books and conference proceedings.A drug information resource containing: American Hospital Formulary System (AHFS), drug formulary for Lucile Packard Children's Hospital (LPCH) and Stanford Hospital & Clinics (SHC), Lexi-Drugs (adverse reactions, dosage and administration, mechanism of action, storage, use, and administration information), Lexi-Calc, Lexi-ID, Lexi-I.V. Compatibility (King Guide), Lexi-Interact, and Lexi-PALS.Cumulative Index to Nursing and Allied Health Literature (CINAHL) contains coverage of nursing and allied health literature.A knowledge database that provides access to topic reviews based on over 6000 clinically relevant articles. The evidence-based content, updated regularly, provides the latest practice guidelines in 59 medical specialtiesProvides critical assessments of systematic reviews compiled from a variety of medical journals.Selects from the biomedical literature original studies and systematic reviews that are immediately clinically relevant and then summarizes these articles in an enhanced abstract with expert commentary.

Multidisciplinary coverage of over 10,000 high-impact journals in the sciences, social sciences, and arts and humanities, as well as international proceedings coverage for over 120,000 conferences.

Includes cited reference searching, citation maps, and an analyze tool.

Features systematic reviews that summarize the effects of interventions and makes a determination whether the intervention is efficacious or not.

Cochrane reviews are created through a strict process of compiling and analyzing data from multiple randomized control trials to ensure comprehensiveness and reliability.

Provides systematic coverage of the psychological literature from the 1800s to the present through articles, book chapters and dissertations.BMJ Clinical Evidence. A clinical information tool built around systematic reviews summarizing the current state of knowledge about prevention and treatment of clinical conditions.PIER (Physicians' Information and Education Resource) is a Web-based decision-support tool designed for rapid point-of-care delivery of up-to-date, evidence-based guidance for primary care physicians.Cochrane Central Register of Controlled Trials (CENTRAL) provides access to 300,000 controlled trials that have been identified the Cochrane Collaboration.Provides drug information targeted for patients.A continually updating drug monograph.The National Guideline Clearinghouse (NGC): A comprehensive database of evidence-based clinical practice guidelines and related documents.MedlinePlus: A repository of health information from the National Library of Medicine. Links are from trusted sites. No advertising, no endorsement of commercial companies or productsLPCH CareNotes via MicroMedex: Patient education handouts customized by LPCH clinical staffMicromedex Lab Advisor: Evidence based laboratory test informationA drug database organized by generic name, trade name and drug class.LPCH / Stanford Hospital Formulary.A goldmine of trusted consumer health information from the world's largest medical library.A trusted source of expert advice for and about kids, providing the information necessary to help patients and parents understand their unique needs.Provides patient handouts from the American Academy of Family Physician.Access to the Stanford Health Library for patients.Lane provides access to over 5,000 eBooks many of which provide helpful background material that will prepare you to better tackle primary literature.

Largest, broadest eBook package; covers all sciences, as well as technology (including software), medicine, and humanities.

In addition to covering Wiley and Springer, MyiLibrary is also the only provider for Oxford and Cambridge University Press titles. No seat restrictions.

A collection of biomedical books that can be searched directly by concept, and linked to terms in PubMed abstracts.

A web-based, decision support system for infectious diseases, epidemiology, microbiology and antimicrobial chemotherapy. The database, updated weekly, currently includes 337 diseases, 224 countries, 1,147 microbial taxa and 306 antibacterial (-fungal, -parasitic, -viral) agents and vaccines.

Over 10,000 notes outline the status of specific infections within each country.

Large number of high quality software and database programming titles from O'Reilly. Other software titles are also available from Sams and Prentice Hall. Limited to 7 concurrent users.Vast collection of software and database programming titles from multiple publishers, including Microsoft Press.Largest provider of engineering-related eBooks; includes titles in computer science and biomedical engineering.Over 4,000 full-text e-books covering scientific and technical information from CRC Press and others. Many handbooks and single volume reference sources.Includes peer-reviewed life science and biomedical research protocols compiled from Methods in Molecular Biology, Methods in Molecular Medicine, Methods in Biotechnology, Methods in Pharmacology and Toxicology, Neuromethods, the Biomethods Handbook, the Proteomics Handbook, and Springer Laboratory Manuals.Contains full text access to selected biomedical and nursing books.

Provides online, full-text access to Springer's journal titles as well as journals from other publishers.

Subjects include: life sciences, chemical sciences, environmental sciences, geosciences, computer science, mathematics, medicine, physics and astronomy, engineering and economics. Also includes eBooks.

Collection of over 8 thousand fulltext titles in engineering, math, and basic and applied biomedical research. Coverage is from 1967 to the present.A library of ebooks on a wide array of topics, digitized and made available online in conjunction with the original publishers.